SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Laserscope (NASDAQ LSCP)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Richard Haugland who wrote (71)8/17/1997 12:02:00 PM
From: Daniel Kahn   of 314
 
Richard, you're right this is a dead thread. But if you're willing I promise to try and help liven it up. Don't know if you watch the First Call earnings estimates on scope, but the one analyst that follows the company reduced his estimate to .29 for this year (was .38) and to .40 for next year (was .50). That is an awful big reduction. The last quarter number was a major league disappointment in spite of the company's attempt to make it sound like a good number. They missed the estimate by 25% and now are reducing numbers going forward. The good news is the stock had already largely discounted the number, dropping from 9 to 4.5, OUCH! Hate to say it, but mgmt has to do a better job delivering results. Hope they have some things in the pipeline that will get people viewing the stock more positive again! I have been in this stock a long time, fortunately I own it right so am not underwater in it but I seriously question how well these guys can compete going forward and whether the stock will be even a market performer. Nice to see it over 5 and with the estimate for next year now at .40 fair value for this stock is probably at least $6! What do you think?
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext